CATEGORIES

Press Release

LATEST

TRENDING

EDITORS CHOICE

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

Lilly commits Insulin Value Program, With $35 Copay Card

Anyone with commercial insurance, and those without insurance at all, can continue filling their monthly prescription of Lilly insulins for $35 through this program.

Wadhwani Foundation $1 Million In Grants for Covid Families in India

Wadhwani Foundation Announces $1 Million In Grants To Immediately Help Indian Families Impacted By Covid-19. Donations to 10 charities and organizations will provide medical and financial assistance to patients and families to help reduce the devastating impact and slow COVID-19 spread.

Trials Validate Cognition Improvement Using PrimeMyBody Hemp Extract

Clinical brain mapping screenings of former NFL players who suffer from cognitive deficits provide supportive data that PrimeMyBody's FOCUS Mind & Body Hemp Extract improved brain performance for 80 percent of screening participants